Signs of Chemoport Infection
Chemoport infections present with distinct clinical patterns: local signs at the insertion site (erythema, tenderness, pain, induration, purulent drainage) or systemic signs (fever, chills, hypotension, sudden-onset sepsis after port use), with the presentation pattern often indicating the causative pathogen. 1
Classification of Chemoport Infections
Chemoport infections can be categorized into three distinct types 1:
- Localized infections at the catheter entrance: Inflammation within ≤2 cm of the insertion site 1
- Port-pocket infections: Clinical signs of infection and inflammation in the subcutaneous pocket of the implanted port system 1
- Catheter-related bloodstream infections (CRBSI): Systemic infection with positive blood cultures and no other identifiable source 1
Local Signs and Symptoms
At the insertion site or port pocket, look for 1:
- Erythema (redness around the port site)
- Tenderness and pain at or around the port
- Induration (hardening of tissue)
- Purulent drainage or exudate from the insertion site
- Warmth over the port area 2
- Swelling at the catheter site 1
Systemic Signs and Symptoms
Systemic manifestations indicating bloodstream infection include 1:
- Fever (most common systemic sign)
- Chills occurring with or without hypotension
- Hypotension suggesting sepsis
- Signs of sepsis of sudden onset, particularly after catheter use or port flush 1
- Catheter dysfunction (inability to flush or draw blood) 1
Clinical Presentation Patterns Linked to Pathogens
The presentation pattern can suggest the causative organism 2:
Port Flush Form Infection
- Onset of fever and chills with or without hypotension immediately following port flush 2
- Typically caused by nosocomial glucose non-fermenting gram-negative bacilli (91% of cases), particularly Acinetobacter baumannii (50%) and Enterobacter cloacae (18%) 2
- Occurs at a mean of 272 days after port implantation 2
Local Inflammatory Form Infection
- Presence of local inflammatory signs (erythema, warmth, tenderness, pus formation) plus systemic infection signs 2
- Predominantly caused by gram-positive cocci (86% of cases), especially Staphylococcus aureus (71%) 2
- Occurs earlier, at a mean of 82 days after port implantation 2
Critical Clinical Context
The mortality rate for CRBSI in cancer patients is 12%–25%, making prompt recognition essential 1. Port-related infections occur in approximately 3%–16% of catheterizations, with an incidence of 0.66 per 1000 catheter days reported in pediatric oncology populations 1, 3.
Common Pitfalls to Avoid
- Do not delay obtaining blood cultures before initiating antimicrobial therapy when infection is suspected 4, 5
- Do not assume absence of local signs excludes infection—systemic CRBSI can occur without visible insertion site inflammation 1
- Do not overlook catheter dysfunction as a potential sign of infection, as thrombosis and infection often coexist 1
- Do not delay catheter removal when S. aureus, Pseudomonas, or Candida species are identified, as these require mandatory port removal 4, 5
Diagnostic Approach When Infection is Suspected
When clinical signs suggest chemoport infection 1, 4:
- Obtain paired blood cultures from the catheter and a peripheral vein before starting antibiotics 1, 4
- If peripheral access is unavailable, draw two blood samples from different catheter lumens at different times 1
- Culture any exudate at the exit site with gram staining 1
- Prepare skin with alcohol, iodine tincture, or alcoholic chlorhexidine (>0.5%) and allow adequate drying time 1, 5
- A differential time to positivity ≥2 hours between catheter and peripheral cultures is highly sensitive and specific for CRBSI 4, 5